About Malate dehydrogenase, mitochondrial
Malate dehydrogenase, mitochondrial (MDH2) is a protein
from Homo sapiens identified by UniProt accession
P40926, 338 residues long.
MolForge cross-references it against 0 known binders and
203 disease associations.
Target properties
| Protein name | Malate dehydrogenase, mitochondrial |
| UniProt accession | P40926 |
| Gene | MDH2 |
| Organism | Homo sapiens |
| Length | 338 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (203)
Diseases linked to this target (Open Targets).
- developmental and epileptic encephalopathy, 51 · score 0.74
- developmental and epileptic encephalopathy · score 0.54
- genetic disorder · score 0.49
- pheochromocytoma-paraganglioma · score 0.37
- hereditary pheochromocytoma-paraganglioma · score 0.37
- mean platelet volume · score 0.31
- eosinophil count · score 0.30
- low density lipoprotein cholesterol measurement · score 0.29
- neutrophil count · score 0.27
- myeloid white cell count · score 0.25
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P40926-F1 | alphafold | PREDICTED | 93.47 | — |
Amino-acid sequence (338 residues)
MLSALARPAS AALRRSFSTS AQNNAKVAVL GASGGIGQPL SLLLKNSPLV SRLTLYDIAH TPGVAADLSH IETKAAVKGY LGPEQLPDCL KGCDVVVIPA GVPRKPGMTR DDLFNTNATI VATLTAACAQ HCPEAMICVI ANPVNSTIPI TAEVFKKHGV YNPNKIFGVT TLDIVRANTF VAELKGLDPA RVNVPVIGGH AGKTIIPLIS QCTPKVDFPQ DQLTALTGRI QEAGTEVVKA KAGAGSATLS MAYAGARFVF SLVDAMNGKE GVVECSFVKS QETECTYFST PLLLGKKGIE KNLGIGKVSS FEEKMISDAI PELKASIKKG EDFVKTLK
Explore Malate dehydrogenase, mitochondrial with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets